Scandion Oncology
Phase 2Overcoming cancer drug resistance. Scandion Oncology is a clinical-stage biotechnology company discovering and developing first-in-class me ...
Founded
2017
Focus
Small Molecules
About
Overcoming cancer drug resistance. Scandion Oncology is a clinical-stage biotechnology company discovering and developing first-in-class me ...
Funding History
2Total raised: $14.7M
IPO$8.2MUndisclosedMay 25, 2018
Series B$6.5MUndisclosedSep 15, 2017
Company Info
TypePrivate
Founded2017
LocationCopenhagen, Denmark
StagePhase 2
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile